Published in Clin Cancer Res on November 01, 1995
The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci U S A (2004) 1.89
Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol (2006) 1.58
Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. Breast Cancer Res (2011) 1.37
Insulin receptor substrates (IRSs) and breast tumorigenesis. J Mammary Gland Biol Neoplasia (2008) 1.07
IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype. J Biol Chem (2009) 1.05
IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors. Cancer Lett (2013) 0.98
Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases. J Clin Pathol (2005) 0.94
Expression of nuclear insulin receptor substrate 1 in breast cancer. J Clin Pathol (2006) 0.93
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer. Breast Cancer Res Treat (2009) 0.85
Type 1 Insulin-Like Growth Factor Receptor/Insulin Receptor Substrate 1 Signaling Confers Pathogenic Activity on Breast Tumor Cells Lacking REST. Mol Cell Biol (2015) 0.80
Differential Expression of IRS-1 and IRS-2 in Uterine Leiomyosarcomas with Distinct Oncogenic Phenotypes: Lack of Correlation with Downstream Signaling Events. Sarcoma (2002) 0.79
Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients. J Cell Mol Med (2014) 0.77
Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only. Hepatol Res (2008) 0.77
Detection of estrogen-independent growth-stimulating activity in breast cancer tissues: implication for tumor aggressiveness. Cancer Microenviron (2013) 0.76
Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer. J Cell Mol Med (2017) 0.75
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res (1997) 1.76
Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J Biol Chem (1995) 1.14
Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res (1995) 1.11
Nitric oxide-releasing NSAIDs: a review of their current status. Drug Saf (2001) 0.93
Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor. Exp Cell Res (1995) 0.91
Antiproliferative effects of nitrosulindac on human colon adenocarcinoma cell lines. Biochem Biophys Res Commun (2001) 0.76
Involvement of cyclooxygenase 2 in the protective effect of 17beta-estradiol on hypercholesterolemic rabbit aorta. Biochem Biophys Res Commun (2000) 0.75
[Pharmacological approach of histamine H3 receptors: use of arterial and bronchiolar perfusion technique]. Ann Pharm Fr (1996) 0.75